Skip to main content
. 2022 Dec 23;16(1):23. doi: 10.3390/ph16010023

Figure 9.

Figure 9

Potent disaccharide-based TLR4 agonists derived from a βGlcN(1↔1)βGlcN scaffold (ββ-DLAMs).